MAIN MENU
QUICK LINKS
CONNECT WITH US

Button

Clinical Trial Details

Title
A Clinical Evaluation of Absorbâ„¢ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesion (ABSORB III)
Study Purpose
The pivotal trial to support the US pre-market approval (PMA) of Absorb BVS. ABSORB III will evaluate the safety and effectiveness of the Absorb BVS System compared to the XIENCE in the treatment of subjects, including those with diabetes mellitus, with ischemic heart disease caused by up to two de novo native coronary artery lesions in separate epicardial vessels.
Study Plan
Subjects will be randomized to treatment with the study device or an FDA approved stent.
Open Enrollment
Contact Name: Emily Green
Contact Phone: (904)244-2794
Investigators

Principal Investigator
Theodore A. Bass, M.D.
Medicine

Sub Investigator
Dominick J. Angiolillo, M.D., Ph.D., FACC
Medicine

Sub Investigator
Martin "M" Zenni, M.D.
Medicine